Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Incidental Extrinsic Cardiac Compression by a Pericardial Mass: Echocardiographic and CT Correlation.

US cardiology·2026

Same author

Paired pre- and post-transplant human immunoprofiling identifies an IFN-γ-JAK1 axis limiting stem-cell-derived RPE engraftment.

Cell stem cell·2026

Same author

Sustained mucosal delivery of SAMT-247 via an intravaginal ring reduces the risk of SIV<sub>mac251</sub> acquisition in vaccinated macaques.

Cell reports. Medicine·2026

Same author

Transmitophagy in the heart: An overview of molecular mechanisms and implications for pathophysiology.

Acta pharmaceutica Sinica. B·2026

Same author

High expression of Rex-orf-I and HBZ mRNAs and bronchiectasis in lung of HTLV-1A/C infected macaques.

Nature communications·2025

Same author

Impact of O-GlcNAcylation Elevation on Mitophagy and Glia in the Dentate Gyrus.

Journal of neurochemistry·2025

Search research articles

Related Experiment Video

Updated: Jan 5, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Immunological Considerations for Retinal Stem Cell Therapy.

Joshua Kramer¹, Kathleen R Chirco¹, Deepak A Lamba^2,3

¹Buck Institute for Research on Aging, Novato, CA, USA.

Advances in Experimental Medicine and Biology

|October 27, 2019

Summary

This summary is machine-generated.

Generating replacement cells for neuronal applications faces challenges due to the immune microenvironment. Understanding retinal immunity and immune rejection is key to improving stem cell therapies for functional restoration.

Keywords:

Cell replacement Complement system Immune modulation Immune rejection Inflammasome Macrophages Microglia Muller glia

More Related Videos

Author Spotlight: Development of an Efficient and Feasible Method of Retinal Pigment Epithelial Cell Freezing

Author Spotlight: Development of an Efficient and Feasible Method of Retinal Pigment Epithelial Cell Freezing

Published on: November 3, 2023

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

Related Experiment Videos

Last Updated: Jan 5, 2026

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases

Published on: June 14, 2021

Author Spotlight: Development of an Efficient and Feasible Method of Retinal Pigment Epithelial Cell Freezing

Author Spotlight: Development of an Efficient and Feasible Method of Retinal Pigment Epithelial Cell Freezing

Published on: November 3, 2023

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

Area of Science:

Neuroscience
Immunology
Regenerative Medicine

Background:

Neuronal tissues are nonregenerative, driving efforts for cell replacement therapies.
Limited functional restoration in cell therapies is often due to the challenging microenvironment for new cells.
The immune microenvironment plays a critical role in the success of these therapies.

Purpose of the Study:

To examine the immune microenvironment of the retina in homeostasis and disease.
To review changes in innate and adaptive immunity affecting cell integration.
To discuss immune rejection in stem cell replacement and potential modulatory strategies.

Main Methods:

Review of current literature on retinal immunity.
Analysis of immune responses in retinal homeostasis and disease states.
Examination of immune rejection mechanisms in cell-based therapies.

Main Results:

The immune microenvironment significantly impacts the integration and function of replacement cells.
Both innate and adaptive immune responses are altered during retinal disease.
Immune rejection poses a barrier to successful stem cell transplantation in the eye.

Conclusions:

Understanding and modulating the retinal immune microenvironment is crucial for effective cell replacement therapies.
Immune-modulatory strategies show promise for improving functional outcomes.
Further research is needed to overcome immune barriers for neuronal regenerative medicine.